Japan's Governance: Articles About Torii Pharmaceutical's Annual General Meeting of Shareholders
This article will discuss about Nikkei's article about "Torii Pharmaceutical opposes Hong Kong investment firm's proposal to ban revolving door"...
300 Views
Screening the Silk Road: Q1 2021 All Cap Screening - Free Cashflow (FCF)
With the value/growth investment style ratio at 20-year lows, we present 27 names which hold characteristics worthy of further review.
348 Views
Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.8k Views